Evidence map›Paper›PMID 40539075›Full record

ArticleFrontiers in immunology2025

Construction and evaluation of a

Jiaxue Yang, Kehan Chen, Yalan Zhu, Tiancheng Xie, Chubin Fang, Chuan Wang, Tian Tang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiaxue Yang *Department of Laboratory Sciences, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Kehan Chen *Department of Laboratory Sciences, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Yalan ZhuDepartment of Laboratory Sciences, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Tiancheng XieDepartment of Laboratory Sciences, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Chubin FangDepartment of Laboratory Sciences, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Chuan Wang *Department of Laboratory Sciences, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Tian Tang *Department of Laboratory Sciences, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: In this study, we developed two multi-epitope vaccine candidates based on Results: Both vaccines demonstrated excellent safety profiles and elicited strong immune responses, significantly reducing Conclusions: These findings underscore the potential of minicell-based vaccines for combating

Indexed as

Bacterial VaccinesDendritic CellsEpitopesHelicobacter InfectionsHelicobacter pyloriSalmonellaAnimalsAntibodies, BacterialAntigens, BacterialCytokinesFemaleMiceMice, Inbred BALB CAntibodies, BacterialAntigens, BacterialBacterial VaccinesCytokinesEpitopesHelicobacter pyloriimmune efficacymulti-epitopeSalmonella minicellsstomach cancervaccine design

Identifiers

PMID40539075
PMCPMC12176869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.